Organs

NEC’s AI Supports Doctors to Detect Neoplasia in Barrett’s Esophagus During Endoscopic Procedures

Retrieved on: 
Friday, May 28, 2021

NEC Corporation (NEC; TOKYO: 6701) today announced the development of an AI technology for supporting doctors to detect neoplasia in Barretts esophagus during endoscopic procedures.

Key Points: 
  • NEC Corporation (NEC; TOKYO: 6701) today announced the development of an AI technology for supporting doctors to detect neoplasia in Barretts esophagus during endoscopic procedures.
  • (Graphic: Business Wire)
    This software is connected to endoscopy processors and automatically notifies users of potential Barretts neoplasia from images captured during endoscopic procedures.
  • Barretts esophagus is a pre-cancerous condition in which the inner lining of the esophagus is replaced by a lining that resembles that of the stomach.
  • Patients with Barretts esophagus have 30-40 fold higher risk of developing cancer of the esophagus as compared to the normal population (*3).

Global Cholangiocarcinoma Market (2021 to 2028) - Featuring Incyte, QED Therapeutics and RenovoRx Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 27, 2021

Cholangiocarcinoma is a form of cancer in which epithelial cells are mutated, which means the cells show characters of epithelial differentiation in the bile duct.

Key Points: 
  • Cholangiocarcinoma is a form of cancer in which epithelial cells are mutated, which means the cells show characters of epithelial differentiation in the bile duct.
  • The bile duct carries a fluid called bile, which is secreted in the liver and stored in the gall bladder.
  • There are two types of bile duct cancer intrahepatic bile duct cancer and extrahepatic bile duct cancer.
  • The collaboration intends to co-develop and commercialize Infigratinib, an oral FGFR1-3 selective inhibitor, for patients dealing with cholangiocarcinoma (bile duct cancer).

NBA's DeMarre Carroll Unveils Tool to Educate Youth About Liver Health

Retrieved on: 
Tuesday, May 25, 2021

ATLANTA, May 25, 2021 /PRNewswire/ --The Carroll Family Foundation (CFF), the non-profit organization founded by professional athlete and liver awareness advocate, DeMarre Carroll is excited to introduce the CFF Liver Hub a web-based platform where youth can access information to learn more about the liver, its function, healthy habits and more all available in a kid-friendly, interactive setting to further educate youth on how to care for their liver.

Key Points: 
  • ATLANTA, May 25, 2021 /PRNewswire/ --The Carroll Family Foundation (CFF), the non-profit organization founded by professional athlete and liver awareness advocate, DeMarre Carroll is excited to introduce the CFF Liver Hub a web-based platform where youth can access information to learn more about the liver, its function, healthy habits and more all available in a kid-friendly, interactive setting to further educate youth on how to care for their liver.
  • He and his wife Iesha founded The Carroll Family Foundation in 2015 with the goal of providing more education and raising awareness about the importance of the liver focusing on liver health in youth.
  • The Carroll Family Foundation is the nonprofit organization founded by NBA player and liver disease awareness advocate DeMarre Carroll and his wife Iesha.
  • For more information about The Carroll Family Foundation and theCFF Liver Hub, please contact Michelle Maysat [email protected] or visit cffliverhealth.com .

Angie Seelal, RPA-C with Advanced Dermatology PC, Shares Tips on Improving the Appearance of Scarred Skin

Retrieved on: 
Thursday, May 13, 2021

"Our body\'s ability to quickly repair its surface and build new tissue following a skin injury is amazing," notes Angie Seelal, a Certified Registered Physician Assistant specializing in Dermatology with Advanced Dermatology PC .

Key Points: 
  • "Our body\'s ability to quickly repair its surface and build new tissue following a skin injury is amazing," notes Angie Seelal, a Certified Registered Physician Assistant specializing in Dermatology with Advanced Dermatology PC .
  • "But the repaired surface, while functional, typically stands out distinctly from the surrounding skin, and the appearance of scars can cause great distress on any individual.
  • "The result is that the repaired skin has a less organized framework of collagen, the protein that provides our skin\'s underlying structure.
  • "\nBio: Angie Seelal, RPA-C is a Certified Physician Assistant through the National Commission of Certification of Physician Assistants.\nAdvanced Dermatology P.C.

Amorepacific Discovers Skin Barrier Regulator EGR3

Retrieved on: 
Thursday, May 13, 2021

The research results were presented under the title of "Skin Barrier Formation by Epigenetic Regulation of EGR3" at the Society for Investigative Dermatology\'s annual academic conference, which took place online on May 3-8.The Society for Investigative Dermatology is the most prestigious academic society in the field of skin research.

Key Points: 
  • The research results were presented under the title of "Skin Barrier Formation by Epigenetic Regulation of EGR3" at the Society for Investigative Dermatology\'s annual academic conference, which took place online on May 3-8.The Society for Investigative Dermatology is the most prestigious academic society in the field of skin research.
  • Keratinocytes in the granular layer of the epidermis play an especially important role in the proper formation and functioning of the skin barrier.
  • At the same time, it was also established that in comprehensively regulating the expression of genes vital for skin barrier formation, EGR3 uses an epigenetic method involving enhancer RNA[i].\nIn fact, Amorepacific achieved much more than simply identifying the role of EGR3 in the barrier-forming process and its epigenetic regulation mechanism; the company also discovered that materials treated with peony root extracts selectively increase EGR3 expression in keratinocytes thereby strengthening the skin barrier.
  • Continuing with the research, the company even went on to turn those findings into cosmetic materials.\nThe skin barrier is the basis of healthy skin and this research conducted by Amorepacific has great significance in that it has established a scientific basis for mitigating skin damage and for helping people maintain healthy skin.

Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

Retrieved on: 
Wednesday, May 12, 2021

The Company offers a portfolio of high-quality, science-based non-prescription skincare products and early to commercial stage prescription products.

Key Points: 
  • The Company offers a portfolio of high-quality, science-based non-prescription skincare products and early to commercial stage prescription products.
  • The portfolio is designed to address preventive care to combating the first signs of aging, as well as all primary aesthetic skin concerns.
  • In Canada, our national sales force calls on aesthetic practitioners and medical aesthetic clinics and medispas using a business to business to consumer model.
  • Pliaglis is a topical local anesthetic cream that provides safe and effective local dermal analgesia on intact skin prior to superficial dermatological procedures.

VoxNeuro Empowers Americans to Take Control of Their Brain Health

Retrieved on: 
Tuesday, May 11, 2021

\xe2\x80\x9cClinicians will have more certainty, with more objective information about how a patient\xe2\x80\x99s brain is functioning.

Key Points: 
  • \xe2\x80\x9cClinicians will have more certainty, with more objective information about how a patient\xe2\x80\x99s brain is functioning.
  • \xe2\x80\x9cSimply put, this technology will empower Americans to take control of their brain health,\xe2\x80\x9d Connolly added.\nVoxNeuro has worked closely with the Principle of Western New York Medical Imaging Group over the past year on market entrance strategy.
  • "\nVoxNeuro is positioned to globally change the way brain health is managed and treated.
  • To learn more, follow VoxNeuro on LinkedIn , Twitter , Instagram , Facebook and YouTube .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210511005877/en/\n'

Protara Therapeutics Announces First Quarter 2021 Financial Results and Business Overview

Retrieved on: 
Thursday, May 6, 2021

The increased R&D expenses were primarily due to increases in manufacturing and regulatory expenses associated with TARA-002.\nGeneral and administrative expenses for the first quarter of 2021 decreased to $6.5 million from $7.1 million for the prior year period.

Key Points: 
  • The increased R&D expenses were primarily due to increases in manufacturing and regulatory expenses associated with TARA-002.\nGeneral and administrative expenses for the first quarter of 2021 decreased to $6.5 million from $7.1 million for the prior year period.
  • NMIBC is cancer found in the tissue that lines the inner surface of the bladder that has not spread into the bladder muscle.
  • Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements.
  • Protara undertakes no obligation to update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise, except as required by law.\n'

Butterbean Organics Voted the Best Natural Mineral Sunscreen Third Year In a Row By Kitchen Stewardship

Retrieved on: 
Sunday, May 2, 2021

The company\'s ethos includes the promise of sustainability in packaging and certified organic ingredient sourcing abilities, empowering small local businesses, and practicing Fair Trade.

Key Points: 
  • The company\'s ethos includes the promise of sustainability in packaging and certified organic ingredient sourcing abilities, empowering small local businesses, and practicing Fair Trade.
  • "Our natural mineral sunscreens aim at creating a barrier on your child\'s delicate skin that will prevent the sun\'s harmful impact to penetrate the epidermis and permanently damage its tissue.
  • Butterbean Organics is grateful for the honorable recognition and strives to continue making a positive impact on the health of our children and the planet.
  • It is in our hands to choose the top quality products for the fragile skin of our children.\n'

Provectus Biopharmaceuticals Announces Acceptance of PV-10® Immunotherapy Abstracts at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting

Retrieved on: 
Wednesday, April 28, 2021

IL PV-10 has been administered to over 450 patients with cancers of the skin and of the liver.

Key Points: 
  • IL PV-10 has been administered to over 450 patients with cancers of the skin and of the liver.
  • It is administered under visual, tactile or ultrasound guidance to superficial malignancies, and under CT or ultrasound guidance to tumors of the liver.
  • Information about the Company\xe2\x80\x99s clinical trials can be found at the National Institutes of Health (NIH) registry, www.clinicaltrial s .gov .
  • For additional information about Provectus, please visit the Company's website at www.provectusbi o .com .\n"